Literature DB >> 29858124

Gallium-68 HBED-CC-PSMA Positron Emission Tomography/Magnetic Resonance Imaging for Prostate Fusion Biopsy.

Kay M Westenfelder1, Beatrice Lentes2, Julia Rackerseder2, Nassir Navab2, Jürgen E Gschwend1, Matthias Eiber3, Tobias Maurer4.   

Abstract

Entities:  

Keywords:  Fusion biopsy; Multiparametric MRI; Prostate cancer; Prostate-specific membrane antigen; Targeted biopsy

Mesh:

Substances:

Year:  2018        PMID: 29858124     DOI: 10.1016/j.clgc.2018.05.009

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN: 1558-7673            Impact factor:   2.872


× No keyword cloud information.
  4 in total

1.  [68Ga]Ga-PSMA-11 in prostate cancer: a comprehensive review.

Authors:  Frédéric Bois; Camille Noirot; Sébastien Dietemann; Ismini C Mainta; Thomas Zilli; Valentina Garibotto; Martin A Walter
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-12-15

2.  68Ga-PSMA PET/CT Combined with PET/Ultrasound-Guided Prostate Biopsy Can Diagnose Clinically Significant Prostate Cancer in Men with Previous Negative Biopsy Results.

Authors:  Chen Liu; Teli Liu; Zhongyi Zhang; Ning Zhang; Peng Du; Yong Yang; Yiqiang Liu; Wei Yu; Nan Li; Michael A Gorin; Steven P Rowe; Hua Zhu; Kun Yan; Zhi Yang
Journal:  J Nucl Med       Date:  2020-02-07       Impact factor: 10.057

3.  Diagnostic performance of 68Ga-PSMA PET/CT in the detection of prostate cancer prior to initial biopsy: comparison with cancer-predicting nomograms.

Authors:  Jingliang Zhang; Shuai Shao; Peng Wu; Daliang Liu; Bo Yang; Donghui Han; Yu Li; Xiaoyu Lin; Wei Song; Milin Cao; Jing Zhang; Fei Kang; Weijun Qin; Jing Wang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01-11       Impact factor: 9.236

4.  Ex vivo treatment of prostate tumor tissue recapitulates in vivo therapy response.

Authors:  Wenhao Zhang; Wytske M van Weerden; Corrina M A de Ridder; Sigrun Erkens-Schulze; Edgar Schönfeld; Titia G Meijer; Roland Kanaar; Dik C van Gent; Julie Nonnekens
Journal:  Prostate       Date:  2018-12-05       Impact factor: 4.104

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.